1099 On Other Exchanges
Symbol
Exchange
1099 is not on other exchanges.

sinopharm group co-h (1099) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SINOPHARM GROUP CO-H (1099)
\

Related News

No related news articles were found.

sinopharm group co-h (1099) Related Businessweek News

View More BusinessWeek News

sinopharm group co-h (1099) Details

Sinopharm Group Co. Ltd., together with its subsidiaries, distributes pharmaceutical and healthcare products in the People’s Republic of China. Its Pharmaceutical Distribution segment offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. This segment distributes medicines, medical devices, and pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. The company’s Retail Pharmacy segment operates or franchises a network of retail drug stores. As of December 31, 2016, this segment had 3,502 retail pharmacies, which included 2,503 retail pharmacies operated by company and 999 operated by franchisees. Its Other Business segment produces and sells pharmaceutical products, chemical reagents, and laboratory supplies; and distributes medical devices, as well as engages in financial leasing. The company also distributes Chinese herbal medicines, antibiotics, and biological products; manages medical project investments, as well as offers consulting and technology training; imports and exports goods and technology; and provides health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it is involved in the rental of properties; and provision of information technology development, as well as business consulting services. The company was founded in 2003 and is based in Shanghai, China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

55,961 Employees
Last Reported Date: 09/15/17
Founded in 2003

sinopharm group co-h (1099) Top Compensated Officers

Chairman & President
Total Annual Compensation: CNY8.0M
Compensation as of Fiscal Year 2016.
sinopharm group co-h
Sinopharm Group Co. Ltd. Presents at Credit Suisse - 8th Annual China Investment Conference, Nov-01-2017

Sinopharm Group Co. Ltd. Presents at Credit Suisse - 8th Annual China Investment Conference, Nov-01-2017 . Venue: Ritz-Carlton Hotel, Shenzhen, Guangdong Province, China.

Sinopharm Group Co. Ltd. Announces Consolidated and Company Earnings Results for the Nine Months Ended 30 September 2017

Sinopharm Group Co. Ltd. announced consolidated and company earnings results for the nine months ended 30 September 2017. For the period, on consolidated basis the company reported total operating revenue of RMB 208,630,836,991.11 as compared to RMB 193,101,515,744.58 for the same period last year. Operating profit was RMB 7,068,868,658.55 as compared to RMB 6,441,529,709.04 for the same period last year. Total profit was RMB 7,076,129,549.13 as compared to RMB 6,906,400,861.09 for the same period last year. Net profit was RMB 5,460,900,062.20 as compared to RMB 5,332,440,502.03 for the same period last year. Net profit attributable to equity holders of the Company was RMB 3,659,841,997.01 as compared to RMB 3,604,404,897.33 for the same period last year. Basic and diluted earnings per share was RMB 1.32 as compared to RMB 1.30 for the same period last year. Net cash flows used from operating activities was RMB 11,806,561,538.56 as compared to Net cash flows from operating activities of RMB 84,887,216.92 for the same period last year. For the period, on company basis the company reported total operating revenue of RMB 13,179,644,528.31 as compared to RMB 13,629,250,385.33 for the same period last year. Operating profit was RMB 804,990,322.17 as compared to RMB 581,815,639.53 for the same period last year. Total profit was RMB 815,046,027.90 as compared to RMB 605,771,661.32 for the same period last year. Net profit was RMB 752,471,886.93 as compared to RMB 532,985,599.71 for the same period last year. Net cash flows used from operating activities was RMB 2,071,693,838.21 as compared to Net cash flows from operating activities of RMB 1,608,886,602.03 for the same period last year.

Sinopharm Group Co. Ltd. to Report Q3, 2017 Results on Oct 27, 2017

Sinopharm Group Co. Ltd. announced that they will report Q3, 2017 results on Oct 27, 2017

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

1099 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1099.
View Industry Companies
 

Industry Analysis

1099

Industry Average

Valuation 1099 Industry Range
Price/Earnings 15.6x
Price/Sales 0.3x
Price/Book 2.3x
Price/Cash Flow 15.5x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SINOPHARM GROUP CO-H, please visit ir.sinopharmgroup.com.cn. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.